Matchpoint Therapeutics, a biotechnology startup seeded by Atlas Venture and Access Biotechnology, emerged from stealth on Friday with plans to develop covalent drugs for autoimmune diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,